What is a stock summary page? Click here for an overview.
Business Description
MyunMoon Pharm Co Ltd
ISIN : KR7017180001
Compare
Compare
Traded in other countries / regions
017180.Korea Index Membership
KOSPI IPO Date
2008-07-10Description
MyunMoon Pharm Co Ltd is a South Korea based company engages in the manufacture and sale of pharmaceutical products. Its products include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs, and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | 21.46 | |||||
| Interest Coverage | 0.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.9 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.1 | |||||
| 3-Year EBITDA Growth Rate | 107.2 | |||||
| 3-Year EPS without NRI Growth Rate | 31.3 | |||||
| 3-Year Book Growth Rate | 6.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 85.06 | |||||
| 9-Day RSI | 75.6 | |||||
| 14-Day RSI | 66.7 | |||||
| 3-1 Month Momentum % | -6.77 | |||||
| 6-1 Month Momentum % | -29.96 | |||||
| 12-1 Month Momentum % | -21.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.87 | |||||
| Quick Ratio | 0.51 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 141.19 | |||||
| Days Sales Outstanding | 68.67 | |||||
| Days Payable | 75.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | -4.47 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.3 | |||||
| Operating Margin % | 1.03 | |||||
| Net Margin % | -1.63 | |||||
| FCF Margin % | -1.47 | |||||
| ROE % | -3.59 | |||||
| ROA % | -1.27 | |||||
| ROIC % | 0.81 | |||||
| 3-Year ROIIC % | -290.79 | |||||
| ROC (Joel Greenblatt) % | 0.94 | |||||
| ROCE % | 1.16 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.3 | |||||
| PB Ratio | 0.57 | |||||
| Price-to-Tangible-Book | 0.58 | |||||
| EV-to-EBIT | 90.06 | |||||
| EV-to-EBITDA | 35.49 | |||||
| EV-to-Revenue | 0.78 | |||||
| EV-to-FCF | -52.08 | |||||
| Price-to-GF-Value | 0.57 | |||||
| Price-to-Projected-FCF | 6.12 | |||||
| Price-to-Median-PS-Value | 0.36 | |||||
| Earnings Yield (Greenblatt) % | 1.12 | |||||
| FCF Yield % | -4.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MyunMoon Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 186,443.052 | ||
| EPS (TTM) (â‚©) | -92 | ||
| Beta | 0.43 | ||
| 3-Year Sharpe Ratio | -1.15 | ||
| 3-Year Sortino Ratio | -1.38 | ||
| Volatility % | 34.34 | ||
| 14-Day RSI | 66.7 | ||
| 14-Day ATR (â‚©) | 37.420713 | ||
| 20-Day SMA (â‚©) | 1578.3 | ||
| 12-1 Month Momentum % | -21.72 | ||
| 52-Week Range (â‚©) | 1412 - 2970 | ||
| Shares Outstanding (Mil) | 33.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MyunMoon Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MyunMoon Pharm Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
MyunMoon Pharm Co Ltd Frequently Asked Questions
What is MyunMoon Pharm Co Ltd(XKRX:017180)'s stock price today?
The current price of XKRX:017180 is â‚©1668.00. The 52 week high of XKRX:017180 is â‚©2970.00 and 52 week low is â‚©1412.00.
When is next earnings date of MyunMoon Pharm Co Ltd(XKRX:017180)?
The next earnings date of MyunMoon Pharm Co Ltd(XKRX:017180) is .
Does MyunMoon Pharm Co Ltd(XKRX:017180) pay dividends? If so, how much?
MyunMoon Pharm Co Ltd(XKRX:017180) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers